NCT04044534View on ClinicalTrials.gov

Intranasal Insulin for Posttraumatic Stress Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
PTSD
Interventions
DRUG

Intranasal insulin

Subjects in this arm will receive intranasal insulin (80 IU per day).

DRUG

Placebo

Subjects in this arm will receive placebo.

Trial Locations (1)

06516

RECRUITING

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

VA Connecticut Healthcare System

FED